What do I need to know about the etonogestrel-relesasing contraceptive implant (Nexplanon)?
- 27 May 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 26 (7) , 394-395
Abstract
The Canadian Paediatric Society endorses long-acting reversible contraception (LARC) methods as first line in the adolescent population ( 1). Previously, the only options on the Canadian market were intrauterine devices (IUDs), either copper or hormonal. The Nexplanon contraceptive implant is a new option for our patients, which is now available following Health Canada approval in 2020.Keywords
This publication has 7 references indexed in Scilit:
- Assessing Weight Status in Adolescent and Young Adult Users of the Etonogestrel Contraceptive ImplantJournal of Pediatric and Adolescent Gynecology, 2019
- Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trialFertility and Sterility, 2018
- Contraceptive care for Canadian youthPaediatrics & Child Health, 2018
- Long-Acting Reversible Contraception and Condom Use Among Female US High School StudentsJAMA Pediatrics, 2016
- Provision of No-Cost, Long-Acting Contraception and Teenage PregnancyNew England Journal of Medicine, 2014
- Contraceptive Failure Rates of Etonogestrel Subdermal Implants in Overweight and Obese WomenObstetrics & Gynecology, 2012
- Nexplanon: the new implant for long-term contraception. A comprehensive descriptive reviewGynecological Endocrinology, 2012